- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05097352
Effects of a Short-term Exercise Intervention on Sleep in Women Exposed to Trauma: A Randomized Controlled Trial
April 15, 2023 updated by: Patrick O'Connor, University of Georgia
Effects of a High-intensity Interval Training (HIIT) Exercise Intervention on Sleep in Women Exposed to Trauma: A Randomized Controlled Trial
This study aims to test whether sleep improvements, following 6 weeks of high-intensity interval training exercise among adult women exposed to a traumatic event, are mediated by improvements in heart rate variability or decreased anxiety and hyperarousal symptoms.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A total of 60 women with below-average sleep quality and physical activity levels who also screen positive for PTSD on the Post-traumatic Diagnostic Scale (PDS-5) will be randomized to either six weeks of exercise training or a waitlist control.
Twenty minutes of high intensity interval training will be performed three times per week for six-weeks.
Heart rate variability will be measured at rest, during, and following a cognitive task.
Psychometric measures supported by strong validity evidence will assess self-reported anxiety and PTSD symptoms, and sleep quality.
Study Type
Interventional
Enrollment (Actual)
41
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Melissa J McGranahan, MS
- Phone Number: 8156669006
- Email: mmcg91@uga.edu
Study Locations
-
-
Georgia
-
Athens, Georgia, United States, 30605
- University of Georgia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 39 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- self-reported exposure to a traumatic event
- persistent (> 1 month) PTSD-related symptoms adequate to screen positive for PTSD or self-reported history of a prior PTSD diagnosed by a health care professional.
- poor sleep quality (Pittsburgh Sleep Quality Index >5)
- failure to meet recommended level of aerobic or resistance training during leisure time. Physical activity for U.S. adults (<150-mins of moderate or 75-mins of vigorous physical activity [or a combination] per week and/or < 2 days a week of resistance training targeting the major muscle groups).
- able to safely perform high-intensity exercise
- aged 18-39 years
- non-smoker
- willing to avoid alcohol and vigorous physical activity 24 hours before visiting the lab
- willing to avoid caffeine for 12 hours before visiting the lab
Exclusion Criteria:
- Pregnant, lactating, or plans to become pregnant over the next 2 months.
- Individuals who started taking medication for anxiety or depression-related symptoms within the last month.
- Individuals currently taking beta-blockers or other medications/substances (marijuana and other illegal drugs) that impact heart rate.
- History of reproductive disorders (e.g., premenstrual dysphoric disorder or polycystic ovary syndrome), cardiovascular (e.g., cardiac arrhythmia), or pulmonary disorders (e.g., asthma).
- Pain intensity of 8 or greater in the thigh or foot in the past month
- Probable alcohol use disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: High Intensity Interval Training (HIIT)
High-intensity interval training will be performed three times a week for a total of six weeks.
|
Twenty minutes of HIIT will be completed three days a week for six weeks.
|
Sham Comparator: Waitlist Control
Waitlist participants were tested on the outcomes at the same time points as the treatment group (i.e., HIIT).
Following completion of the waitlist treatment, participants will be eligible to receive a supervised exercise program (no data will be collected).
The waitlist participants formed a no-treatment control group.
|
Waitlist participants will be tested on the outcomes at the same time points as the treatment group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pittsburg Sleep Quality Index (PSQI)
Time Frame: Change from Baseline to week 7
|
The PSQI consists of 19 items.
Scores range from 0-21, higher scores indicate poorer sleep quality.
A global score ≥5 indicates poor sleep quality.
|
Change from Baseline to week 7
|
Heart Rate Variability
Time Frame: Change from Baseline to Week 7
|
High frequency (HF) and low frequency (LF) domains of heart rate variability will be assessed before, during, and following a cognitive task.
|
Change from Baseline to Week 7
|
State Trait Anxiety Inventory (STAI-Y2)
Time Frame: Change from Baseline to Week 7
|
The STAI-Y2 Trait subscale consists of 20-item and will assess anxiety.
The total score ranges from 20-80; higher scores indicate greater trait anxiety.
|
Change from Baseline to Week 7
|
The Posttraumatic Diagnostic Scale-5 (PDS-5)
Time Frame: Change from Baseline to Week 7
|
The PDS-5 consists 24-item scale and will assess PTSD symptoms based on the diagnostic criteria for the DMS-5.
The full PDS-5 assesses trauma history, symptom onset, and index of trauma.
The total score ranges from 0-80.
|
Change from Baseline to Week 7
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Patrick J O'Connor, PhD, University of Georgia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 24, 2022
Primary Completion (Actual)
March 31, 2023
Study Completion (Actual)
March 31, 2023
Study Registration Dates
First Submitted
September 28, 2021
First Submitted That Met QC Criteria
October 15, 2021
First Posted (Actual)
October 28, 2021
Study Record Updates
Last Update Posted (Actual)
April 18, 2023
Last Update Submitted That Met QC Criteria
April 15, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PROJECT00004322
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Disorders
-
Kansas State UniversityAugusta University; Dartmouth College; University of CincinnatiEnrolling by invitationMental Disorders, Severe | Mental Illness PersistentUnited States
-
VA Boston Healthcare SystemUS Department of Veterans AffairsCompletedMental Health DisordersUnited States
-
Virginia Commonwealth UniversityCompletedMental Health DisordersUnited States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMental Health DisordersCongo
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedMental Health DisordersNorway
-
York UniversityCanadian Institutes of Health Research (CIHR); North York General HospitalCompletedMental Health DisordersCanada
-
University of ManchesterEuropean Research CouncilRecruitingMental Disorders, SevereUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...Active, not recruitingMental Disorders, SevereSpain
-
University of North Carolina, Chapel HillU.S. Department of JusticeCompletedMental Disorders, SevereUnited States
-
Liga Romana pentru Sanatate MintalaPsychiatric Hospital for Chronic Patients Siret, Suceava, RomaniaUnknown
Clinical Trials on High Intensity Interval Training (HIIT)
-
Université de SherbrookeRecruiting
-
Mayo ClinicRecruitingCardiac RehabilitationUnited States
-
Karolinska University HospitalKarolinska InstitutetUnknownDermatomyositis | PolymyositisSweden
-
Chang Gung Memorial HospitalCompletedHeart Failure | Morality | Remodeling, VentricularTaiwan
-
Brock UniversityCompletedCardiovascular Diseases | Metabolic SyndromeCanada
-
McMaster UniversityUnknown
-
University of North Carolina, Chapel HillEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedKnee OsteoarthritisUnited States
-
Amsterdam UMC, location VUmcRecruitingExercise | Brain Tumor, PrimaryNetherlands
-
VA Office of Research and DevelopmentAtlanta VA Medical CenterNot yet recruitingStroke | Stroke Rehabilitation | Walking, Difficulty | Lower Extremity Weakness, SpasticUnited States
-
Karolinska InstitutetRecruitingOverweight | Type 1 DiabetesSweden